Back to Journals » OncoTargets and Therapy » Volume 7

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis

Total article views   HTML views PDF downloads Totals
10,244 Dovepress* 9,303+ 1,468 10,771
PubMed Central* 941 365 1,306
Totals 10,244 1,833 12,077
*Since 18 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar